Healthcare
TPG to exit India cancer business for $283m
Asia Healthcare Holdings (AHH), an India-focused healthcare platform owned by TPG Growth, has agreed to sell cancer hospital chain Cancer Treatment Services International (CTSI) to US-based radiology player Varian Medical Systems for $283 million.
Qiming leads Series B for Chinese hospital chain operator
Qiming Venture Partners has led a Series B round of nearly RMB100 million ($14 million) for Shanghai-based private hospital chain operator SinoUnited Health.
Matrix exits India eye care chain
Matrix Partners India has made a full exit from Centre for Sight, operator of a chain of eye clinics in India, to Mahindra Partners after a holding period of nearly 10 years.
PE investors commit $1b to JD.com's healthcare unit
A group including CITIC Private Equity, CICC Capital and Baring Private Equity Asia has agreed to invest $1 billion in the healthcare unit of Chinese e-commerce giant JD.com, acquiring a combined stake of 14.5%.
Chinese gene tech equipment maker raises $200m
MGI Tech, a Chinese manufacturer of equipment used in gene sequencing, has raised $200 million in funding led by Goldstone Investment, the PE arm under CITIC Securities, Green Pine Capital Partners and Orient Securities Capital Investment.
LeapFrog raises $700m for third impact fund
LeapFrog Investments has raised $700 million for its third fund with a view to investing in healthcare and financial services companies in emerging Asia and Africa. It initially targeted a corpus of $600 million.
Emerging Asia healthcare: Pilot programs
Buy-and-build strategies, a mainstay of the PE toolkit in developed markets, are gaining exposure in emerging Asia’s healthcare sector. Proving a viable exit path will be the key to widespread adoption
Accel, Kalaari, Chiratae invest in India's CureFit
Indian health and fitness start-up CureFit has raised $75 million from a group of investors including Accel Partners, Kalaari Capital, and Chiratae Ventures.
BlueChilli launches health-tech accelerator in Singapore
Australia’s BlueChilli has launched a health-tech accelerator in Singapore in cooperation with the local government as part of a broader pivot toward the region.
C-Bridge closes third healthcare fund at $850m
C-Bridge Capital has closed its third healthcare fund - which covers Asia but is most active in China - at $850 million, after increasing the hard cap. It is the largest dedicated healthcare vehicle raised for deployment in Asia by an independent private...
TPG-backed Asia Healthcare acquires India fertility clinic
Asia Healthcare Holdings (AHH), a healthcare-focused operating and investment platform managed by TPG Growth, has agreed to acquire Nova IVI Fertility, an operator of in vitro fertilization (IVF) clinics based in India.
China-US biopharma player raises $47m Series C
Sirnaomics, a China and US-based biopharmaceutical company specializing in gene therapeutics, has raised $47 million in Series C funding across two tranches.
Cancer drug developer Tot Biopharm files for HK IPO
Tot Biopharm, a private equity-backed Chinese cancer drug developer, has filed for a Hong Kong IPO under rules that allow for listings by pre-revenue biotech companies.
Chinese online drug store Yao123 raises $45m Series B
Healthcare-focused GTJA Investment Group has led a RMB300 million ($45 million) Series B round for Chinese online pharmacy operator Yao123.
Blackstone buys Korean drug distributor
The Blackstone Group has acquired Geo-Young, a South Korean wholesale drug distributor, working in conjunction with the founders. It facilitates an exit for local GP Anchor Equity Partners, which invested in the company in 2013.
SBI leads $17m Series B for India health-tech player
SBI Ven Capital, a Singapore-based division of Japan’s SBI Group, has led a $17.2 million Series B round for Mfine, an Indian healthcare technology player that uses artificial intelligence (AI).
Panacea closes debut China healthcare fund at $180m
Panacea Venture, a Chinese GP founded by KPCB alumnus James Huang that specializes in early-stage healthcare investments, has closed its debut fund at approximately $180 million.
Malaysia's RHL Ventures launches SME fund
RHL Ventures has launched a MYR100 million ($24.2 million) fund focused on small to medium-sized enterprises (SME) with a cornerstone investment from government-owned SME Corp Malaysia.
TA invests in India fertility business
TA Associates has acquired a significant minority stake in Indira IVF, an India-based provider of infertility services.
IDG, CDH back China cancer testing kits producer
IDG Capital Partners and CDH Investments have led an RMB300 million ($45 million) Series B round for China-based Creative Biosciences, a manufacturer of testing kits for colon cancer.
Sequoia China, HighLight back biotech player Cullgen
Sequoia Capital China and HighLight Capital have led a $16 million Series A round for Cullgen, a biotech company that develops treatments for cancer by targeting previously “undruggable” cellular proteins.
LP interview: HESTA
As demand for private equity grows among institutional investors globally, HESTA is focusing on building its internal unlisted assets expertise to connect with potential fund managers on their own terms
Shiyu Capital closes second renminbi fund at $477m
Shiyu Capital, which focuses on growth-stage investments in Chinese healthcare companies, has closed its second renminbi-denominated fund at RMB3.2 billion ($477 million), beating the RMB3 billion target.
Deal focus: Everstone revisits India’s hospitals
Everstone Group acquires Sahyadri Hospitals to serve as the seed asset for a planned national healthcare delivery strategy
